484
Participants
Start Date
June 13, 2023
Primary Completion Date
December 31, 2027
Study Completion Date
June 30, 2028
RP-6306
Dose and schedule will be assigned at enrolment
Gemcitabine
Dose and schedule will be assigned at enrolment
Observation
Monitoring arm
Niraparib
Dose and schedule will be assigned at enrolment
Fulvestrant
Dose and schedule will be assigned at enrolment
RP-3500
Dose and schedule will be assigned at enrolment
RECRUITING
Arthur J.E. Child Comprehensive Cancer Centre, Calgary
RECRUITING
BCCA - Kelowna, Kelowna
RECRUITING
BCCA - Vancouver, Vancouver
RECRUITING
QEII Health Sciences Centre, Halifax
RECRUITING
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
RECRUITING
Kingston Health Sciences Centre, Kingston
RECRUITING
Ottawa Hospital Research Institute, Ottawa
SUSPENDED
Odette Cancer Centre, Toronto
RECRUITING
University Health Network, Toronto
RECRUITING
The Jewish General Hospital, Montreal
Canadian Cancer Trials Group
NETWORK